Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials
Bays, Harold E., Rosenson, Robert S., Baccara-Dinet, Marie T., Louie, Michael J., Thompson, Desmond, Kees Hovingh, G.Мова:
english
Журнал:
Cardiovascular Drugs and Therapy
DOI:
10.1007/s10557-018-6792-z
Date:
April, 2018
Файл:
PDF, 283 KB
english, 2018
File converter
Більше результатів пошуку
More benefits 
